PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) › Total LiabilitiesPROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $3.70M2011: $3.33M2012: $1.81M2013: $13.38M2014: $994.3K2015: $4.12M2016: $2.14M2017: $13.46M2018: $19.41M2019: $25.55M2020: $30.80M2021: $7.70M2022: $8.27M2023: $9.04M2024: $6.98M2025: $7.00M$7.00M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$7.00M+0.4%2024$6.98M-22.9%2023$9.04M+9.4%2022$8.27M+7.3%2021$7.70M-75.0%2020$30.80M+20.5%2019$25.55M+31.7%2018$19.41M+44.2%2017$13.46M+528.2%2016$2.14M-48.1%2015$4.12M+314.7%2014$994.3K-92.6%2013$13.38M+638.8%2012$1.81M-45.6%2011$3.33M-10.1%2010$3.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share